Hilltop National Bank’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$538K Buy
22,328
+3,376
+18% +$88.3K 0.11% 149
2026
Q1
$532K Buy
18,952
+662
+4% +$17.6K 0.13% 147
2025
Q4
$455K Sell
18,290
-672
-4% -$16.9K 0.11% 148
2025
Q3
$483K Sell
18,962
-2,425
-11% -$59.9K 0.12% 143
2025
Q2
$518K Buy
+21,387
New +$499K 0.14% 139
2024
Q4
$506K Buy
19,077
+1,450
+8% +$39.3K 0.15% 128
2024
Q3
$510K Sell
17,627
-374
-2% -$10.9K 0.15% 131
2024
Q2
$504K Buy
18,001
+648
+4% +$17.8K 0.16% 133
2024
Q1
$482K Buy
+17,353
New +$482K 0.16% 144

Other funds holding PFE

Hilltop National Bank's PFE Position: Q2 2026 in Review

Hilltop National Bank increased its Pfizer (PFE) stake by 18% in Q2 2026, buying an estimated $88.3K and bringing the position to 22,328 shares worth $538K. The position accounts for 0.11% of the portfolio, ranked #149.

Hilltop National Bank first reported a position in PFE in Q1 2024 and has held it in 9 quarters since. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Hilltop National Bank held 22,328 shares of Pfizer worth $538K as of Q2 2026.
  • Hilltop National Bank bought 3,376 Pfizer shares in Q2 2026, an estimated $88.3K.
  • Pfizer made up 0.11% of Hilltop National Bank's portfolio in Q2 2026, its #149 holding.
  • Hilltop National Bank first reported a position in Pfizer in Q1 2024 and has held it in 9 quarters since.
  • 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Hilltop National Bank's 13F filing for Q2 2026, filed 2 Jul 2026.